Works matching IS 00778923 AND DT 2017 AND VI 1407 AND IP 1
Results: 8
How to select a nanosimilar.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 50, doi. 10.1111/nyas.13382
- By:
- Publication type:
- Article
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 75, doi. 10.1111/nyas.13547
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 1, doi. 10.1111/nyas.13251
- Publication type:
- Article
Iron sucrose: assessing the similarity between the originator drug and its intended copies.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 63, doi. 10.1111/nyas.13517
- By:
- Publication type:
- Article
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 17, doi. 10.1111/nyas.13461
- By:
- Publication type:
- Article
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 39, doi. 10.1111/nyas.13347
- By:
- Publication type:
- Article
WHO standards for biotherapeutics, including biosimilars: an example of the evaluation of complex biological products.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 5, doi. 10.1111/nyas.13434
- By:
- Publication type:
- Article
Equivalence and regulatory approaches of nonbiological complex drug products across the United States, the European Union, and Turkey.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 26, doi. 10.1111/nyas.13505
- By:
- Publication type:
- Article